AUS
NZ
UK
CA
USA
IND
.jpg)
Morgan Stanley Finance LLC has issued Contingent Income Auto-Callable Securities totaling $888,000, priced on July 16, 2026, and fully backed by Morgan Stanley. These three-year structured notes are linked to International Business Machines Corporation (IBM) stock performance and offer a contingent annual coupon rate of 16.00%, while exposing investors to principal risk if IBM shares decline. Designed for investors in fee-based advisory accounts, these securities require acceptance of potential total loss of principal in exchange for the chance of above-market coupon payments.
Key Points
- NYSE: MS-PQ
- Morgan Stanley Finance LLC issued $888,000 of Contingent Income Auto-Callable Securities guaranteed by Morgan Stanley, maturing July 19, 2029
- Contingent 16.00% annual coupon payable only if IBM stock closes at or above 50% of strike price; principal at risk if final level falls below downside threshold
- Automatic early redemption eligibility starts January 19, 2027, if IBM stock closes at or above call threshold of $219.05
Structured Notes Terms and Underlying Asset Details
Issued under Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program, these Contingent Income Auto-Callable Securities are fully and unconditionally guaranteed by Morgan Stanley but remain unsecured obligations without any security interest in IBM stock. Each note has a principal amount of $1,000, aggregating to $888,000, with an original issue date of July 21, 2026. The underlying asset is IBM capital stock, with a strike and pricing date of July 16, 2026. The notes mature on July 19, 2029, but may be redeemed early on any of 32 monthly redemption determination dates starting January 19, 2027.
The strike price is set at $219.05, reflecting IBM's stock price on the pricing date. This level serves as the reference for contingent coupon payments and automatic redemption triggers. Unlike traditional bonds, these notes do not pay regular interest but offer contingent income based on IBM stock's performance relative to specified thresholds.
Contingent Coupon Terms and Payment Criteria
The notes pay a contingent coupon at an annual rate of 16.00%, conditional on IBM stock closing at or above the coupon barrier level of $109.525 (50% of the strike price) on each observation date. Coupons are paid only if this condition is met on monthly observation dates throughout the notes’ life.
If IBM stock closes below $109.525 on any observation date, no coupon will be paid for that period. Consequently, investors risk receiving no interest income if IBM shares decline substantially. This contingent coupon structure exposes investors to potential extended periods without income while holding securities that may decrease in value due to underlying stock performance.
Automatic Early Redemption Features
Starting January 19, 2027, the notes become eligible for automatic early redemption on any redemption determination date if IBM stock closes at or above the call threshold of $219.05 (100% of the strike price). Upon such an event, investors receive the stated principal plus the contingent coupon for that period. There are 32 monthly redemption determination dates through June 18, 2029, with early redemption payments occurring approximately three business days later.
This feature caps upside potential, as investors will not benefit from IBM stock appreciation beyond the strike price once early redemption occurs. While advantageous in rising markets—ensuring principal and accrued coupons without further exposure—it limits participation in significant stock gains beyond the initial level.
Principal Risk and Downside Threshold Protection
If the notes are not redeemed early, maturity payments depend on IBM stock’s final level relative to the downside threshold. Investors receive full principal plus any final contingent coupon if IBM stock closes at or above this threshold.
If IBM’s final stock price falls below the downside threshold, investors incur losses proportional to the decline—losing 1% of principal for every 1% drop in IBM stock price—potentially resulting in total loss of principal. This downside risk requires investors to accept the possibility of losing their entire initial investment due to adverse stock performance.
Pricing, Fees, and Distribution Details
The notes were issued at $1,000 each on July 16, 2026. Morgan Stanley & Co. LLC, acting as agent, earned $2.50 per note in commissions totaling $2,220 on the $888,000 issuance. Net proceeds to Morgan Stanley Finance LLC were $997.50 per note, or $885,780 total. The estimated value at pricing was $985.40 per note, indicating a premium over estimated intrinsic value.
Sales are restricted to fee-based advisory accounts. Morgan Stanley & Co. plans to sell all purchased notes to an unaffiliated dealer at $997.50 per note for resale at the public price of $1,000. Notably, Morgan Stanley & Co. will not receive sales commissions, reflecting a distribution strategy targeting fee-based advisory clients with distinct fee structures from commission-based accounts.
Credit Risk and Guarantee Considerations
Although fully guaranteed by Morgan Stanley, payments depend on the creditworthiness of both Morgan Stanley Finance LLC and Morgan Stanley. Investors face credit risk of potential default, which could lead to partial or total loss of investment. These notes are unsecured and provide no claim on IBM stock or other collateral.
Investors rely solely on Morgan Stanley’s ability to meet obligations; financial distress at Morgan Stanley could impair guarantee value. The filing does not disclose current credit ratings, requiring investors to independently assess Morgan Stanley’s financial strength.
Risk Profile and Investor Suitability
These securities suit investors seeking potentially above-market income with acceptance of significant principal loss risk and the possibility of no coupon payments. The 16.00% contingent coupon rate reflects elevated risk compared to conventional fixed income. Automatic early redemption limits upside participation beyond the strike price.
Investors must be prepared for total loss of principal due to contingent coupon conditions and downside threshold risks. This investment carries a risk profile substantially different from traditional bonds, demanding strong conviction in IBM stock performance and high risk tolerance.
Regulatory Registration and Disclosure
Registered under Nos. 333-293641 and 333-293641-01, these securities are offered pursuant to a Pricing Supplement filed under Rule 424(b)(2), supported by Product and Tax Supplements and a Prospectus dated April 8, 2026. The SEC and state regulators have not approved or disapproved the securities or verified the completeness of offering documents.
These notes are not bank deposits, are uninsured by FDIC or any government agency, and are not bank obligations. Investors bear responsibility for understanding terms, risks, and performance mechanics, with detailed risk disclosures available in accompanying supplements and prospectuses.
Market Outlook and Monitoring Recommendations
The $888,000 issuance represents a moderate-sized offering of these structured notes. Investors should closely monitor IBM stock relative to coupon barrier ($109.525) and call threshold ($219.05) levels. The first early redemption determination date on January 19, 2027, is a critical milestone for potential early call decisions.
Tracking Morgan Stanley’s credit profile is also essential, as guarantee value depends on its financial health. IBM stock performance will primarily drive returns, while downside leverage amplifies losses. Investors should establish monitoring strategies for both IBM stock price movements and Morgan Stanley credit developments.
